- Home
- BMRN vs CIEN Comparison
BMRN vs CIEN Comparison
Compare BMRN & CIEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- CIEN
- Stock Information
- Founded
- BMRN 1996
- CIEN 1992
- Country
- BMRN United States
- CIEN United States
- Employees
- BMRN N/A
- CIEN N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- CIEN Telecommunications Equipment
- Sector
- BMRN Health Care
- CIEN Utilities
- Exchange
- BMRN Nasdaq
- CIEN Nasdaq
- Market Cap
- BMRN 11.3B
- CIEN 12.8B
- IPO Year
- BMRN 1999
- CIEN 1997
- Fundamental
- Price
- BMRN $57.77
- CIEN $116.72
- Analyst Decision
- BMRN Buy
- CIEN Buy
- Analyst Count
- BMRN 23
- CIEN 15
- Target Price
- BMRN $93.14
- CIEN $113.96
- AVG Volume (30 Days)
- BMRN 1.8M
- CIEN 2.5M
- Earning Date
- BMRN 10-28-2025
- CIEN 09-04-2025
- Dividend Yield
- BMRN N/A
- CIEN N/A
- EPS Growth
- BMRN 154.69
- CIEN 3.32
- EPS
- BMRN 3.40
- CIEN 0.98
- Revenue
- BMRN $3,063,608,000.00
- CIEN $4,541,635,000.00
- Revenue This Year
- BMRN $13.32
- CIEN $16.41
- Revenue Next Year
- BMRN $9.37
- CIEN $10.12
- P/E Ratio
- BMRN $16.97
- CIEN $118.92
- Revenue Growth
- BMRN 18.36
- CIEN 12.97
- 52 Week Low
- BMRN $52.93
- CIEN $49.21
- 52 Week High
- BMRN $90.01
- CIEN $122.00
- Technical
- Relative Strength Index (RSI)
- BMRN 48.39
- CIEN 77.87
- Support Level
- BMRN $55.99
- CIEN $90.00
- Resistance Level
- BMRN $59.79
- CIEN $122.00
- Average True Range (ATR)
- BMRN 1.37
- CIEN 3.61
- MACD
- BMRN -0.05
- CIEN 2.27
- Stochastic Oscillator
- BMRN 46.84
- CIEN 85.95
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About CIEN Ciena Corporation
Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.